Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07146204Not ApplicableNot Yet Recruiting

First in Human Trial of R-Star: A Novel Robotic System for Minimally Invasive Coronary Artery Procedures.

Role: lead

NCT05853419Recruiting

Change History and Adopt a Robotic SolutioN for anGioplasty procedurE

Role: lead

NCT05093127Completed

CArotid Robotic Procedure Evaluation

Role: lead

NCT04163393Not ApplicableCompleted

R-One Efficiency For PCI Evolution With Robotic Assistance

Role: lead

All 4 trials loaded